RxDoctor Payments Data

Gary Birnbaum, MD

Family Medicine · San Francisco, CANPI 1972685972

Payments from drug & device makers

$1,267in general payments, 2019–2025

Across 69 payments — averaging $18.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$241
  • Pfizer$146
  • Amgen$121
  • Boehringer Ingelheim$110
  • AstraZeneca$89
  • Lilly USA, LLC$89
  • plus $471 from 11 others

What the payments were for

  • Food & beverage$1,267100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,267 in reported general payments places this provider in the 75th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$173,803
Medicare patients
123
Services billed
1,855

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban55$20,602
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$14,898
MyrbetriqMirabegron42$9,366
BreynaBudesonide/Formoterol Fumarate15$4,812
Perphenazine15$948
Pregabalin22$842
Lacosamide11$769
Tamsulosin Hcl24$754
Atorvastatin Calcium28$740
Gabapentin33$663
Mirtazapine14$580
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen38$548
Rosuvastatin Calcium28$540
Colchicine17$528
Ezetimibe18$428

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$146$20,60255 claims
Astellas Pharma US IncMyrbetriq$79$9,36642 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 10,533 family medicine providers in California.

Other family medicine in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →